AIGH Capital Management »

Vanda Pharmaceuticals shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $18M 2.0M 8.82
2020-12-31 $4.6M 350k 13.14

More positions owned by AIGH Capital Management

Sandisk Corp (SNDK)
Zoom Communications Call Call Option
Castle Biosciences (CSTL)
Personalis Ord (PSNL)
Nlight (LASR)
Day One Biopharmaceuticals I (DAWN)
Vanda Pharmaceuticals (VNDA)
Bk Technologies Corporation Com New (BKTI)
Domo Com Cl B (DOMO)
Esperion Therapeutics (ESPR)
Kyverna Therapeutics (KYTX)
Fennec Pharmaceuticals (FENC)
Lightpath Technologies Com Cl A (LPTH)
Abeona Therapeutics Com New (ABEO)
Zevra Therapeutics Call Call Option

View all positions for AIGH Capital Management

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Millennium Management
Dimensional Fund Advisors
Tang Capital Management
Acadian Asset Management
AIGH Capital Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Empire Financial Management Company
Federated Investors

View all funds holding Vanda Pharmaceuticals